Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 10, 1999

View Archived Issues

BioTransplant/MGH report extensively on xenotransplantation research at recent congress

Exelixis and Pharmacia & Upjohn expand collaboration

New data reported for Tamiflu as influenza treatment and prophylaxis

HepaVec acquires majority stake in MondoGen

D-Pharm completes toxicity testing of DP-b99 in preparation for phase I trials later this year

Cromafiban stands head and shoulders above others in its class

CombiChem reaches second milestone in collaboration with Teijin

Third quarter activities summarized by MedImmune

BMS reports R&D progress during the third quarter

Anti-H. pylori compound isolated from Acinetobacter at Takeda laboratories

Japanese researchers present new protein-tyrosine-phosphatase inhibitors

Dainippon discloses new compounds useful for the treatment or prophylaxis of liver disease

R&D highlights at Corixa during 3rd quarter

Vasopeptidase inhibitor steals the show at AHA

Kowa's new antiallergic agents inhibit IgE antibody production

Pyridone ACAT inhibitors in development at Sumitomo

Inhibition of telomerase as anticancer strategy under study at Chugai

Studies on absorption of ME-3229 in rat intestinal segments

Inhibitors of cytokine-mediated eosinophil survival as potential agents for asthma

News from AHA: Bayer presents promising new treatment for atherosclerosis

Aronex to lead further development of new liposomal platinum product

Teva licenses European rights to Parkinson's disease drugs to Lundbeck

Preclinical results indicate potential utility of JMR-193 in myocardial perfusion imaging

Specific inhibitors of cancer cell mitogenic pathways tested in combination with radiation

Novel photosensitizer from Miravant prevents postangioplasty restenosis in pig model

Small-molecule inhibitor of receptors of the EGF family may offer superior alternative to Herceptin

Nippon Zoki compound evaluated in diabetic patients with renal failure

Farnesyltransferase inhibitors + radiation synergistic in human tumors expressing mutated ras

Results of phase II trial of GA-EPO presented at ASN

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...